HC Surgical Specialists Limited (SGX:1B1)
Singapore · Delayed Price · Currency is SGD 0.3300
0.00 (0.00%)
At close: Aug 11, 2026
HC Surgical Specialists Cash Flow Statement
Financials in millions SGD. Fiscal year is June - May.
Millions SGD. Fiscal year is Jun - May.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Net Income | 6.98 | 8.44 | 3.85 | 2.92 | 6.38 |
Depreciation & Amortization | 2 | 1.94 | 1.79 | 1.74 | 1.67 |
Other Amortization | - | - | - | 0 | 0 |
Loss (Gain) From Sale of Assets | - | - | - | 0.02 | 0.02 |
Asset Writedown & Restructuring Costs | -0.05 | 0 | 0.16 | 0.81 | 0.81 |
Loss (Gain) From Sale of Investments | -1.65 | -0.49 | 0.06 | 1.6 | -0.99 |
Loss (Gain) on Equity Investments | -0.96 | -0.78 | 0 | -0.04 | -0.02 |
Provision & Write-off of Bad Debts | 0.05 | -0 | 0.25 | 0 | 0 |
Other Operating Activities | 0.12 | -2.02 | 0.51 | 0.26 | -0.42 |
Change in Accounts Receivable | 0.47 | 0.37 | -0.36 | -0.31 | 0.69 |
Change in Inventory | 0.08 | 0.06 | 0.07 | -0.07 | -0.06 |
Change in Accounts Payable | 0.01 | -0.23 | -0.04 | 0.28 | -1.02 |
Change in Other Net Operating Assets | 0.2 | -0.05 | 0.02 | 0.01 | -0.01 |
Operating Cash Flow | 7.24 | 7.23 | 6.3 | 7.22 | 7.06 |
Operating Cash Flow Growth | 0.19% | 14.72% | -12.69% | 2.31% | -34.37% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Capital Expenditures | -0.1 | -0.49 | -0.07 | -0.71 | -0.22 |
Sale of Property, Plant & Equipment | - | - | 0 | 0.01 | 0.02 |
Cash Acquisitions | -0.05 | -0.67 | -1.33 | -1.81 | -2.51 |
Investment in Securities | 0.35 | 0.12 | 3.45 | -0.03 | -0.1 |
Other Investing Activities | 0.52 | 0.6 | 0.79 | 0.82 | 0.82 |
Investing Cash Flow | 0.72 | -0.44 | 2.84 | -1.72 | -1.99 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Long-Term Debt Repaid | -1.65 | -2.76 | -2.51 | -2.49 | -2.34 |
Total Debt Repaid | -1.65 | -2.76 | -2.51 | -2.49 | -2.34 |
Net Debt Issued (Repaid) | -1.65 | -2.76 | -2.51 | -2.49 | -2.34 |
Repurchase of Common Stock | - | -0.12 | - | - | - |
Common Dividends Paid | -3.19 | -2.31 | -2.62 | -3.28 | -5.51 |
Other Financing Activities | -0.44 | -3.87 | -2.85 | -0.48 | -1.28 |
Financing Cash Flow | -5.28 | -9.06 | -7.97 | -6.24 | -9.12 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Net Cash Flow | 2.68 | -2.27 | 1.18 | -0.74 | -4.06 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Free Cash Flow | 7.15 | 6.75 | 6.23 | 6.51 | 6.84 |
Free Cash Flow Growth | 5.97% | 8.27% | -4.32% | -4.74% | -33.25% |
Free Cash Flow Margin | 36.23% | 34.95% | 32.85% | 33.95% | 35.20% |
Free Cash Flow Per Share | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 |
Levered Free Cash Flow | 5.41 | 0.37 | 3.36 | 7.77 | 6.82 |
Unlevered Free Cash Flow | 5.48 | 0.53 | 3.68 | 8.17 | 7.11 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash Interest Paid | 0.11 | 0.14 | 0.16 | 0.17 | 0.18 |
Cash Income Tax Paid | 0.56 | 0.64 | 1.02 | 1.02 | 1.44 |
Change in Working Capital | 0.75 | 0.14 | -0.31 | -0.09 | -0.4 |